Gijsen, M.; Dreesen, E.; Van Daele, R.; Annaert, P.; Debaveye, Y.; Wauters, J.; Spriet, I.
Pharmacokinetic/Pharmacodynamic Target Attainment Based on Measured versus Predicted Unbound Ceftriaxone Concentrations in Critically Ill Patients with Pneumonia: An Observational Cohort Study. Antibiotics 2021, 10, 557.
https://doi.org/10.3390/antibiotics10050557
AMA Style
Gijsen M, Dreesen E, Van Daele R, Annaert P, Debaveye Y, Wauters J, Spriet I.
Pharmacokinetic/Pharmacodynamic Target Attainment Based on Measured versus Predicted Unbound Ceftriaxone Concentrations in Critically Ill Patients with Pneumonia: An Observational Cohort Study. Antibiotics. 2021; 10(5):557.
https://doi.org/10.3390/antibiotics10050557
Chicago/Turabian Style
Gijsen, Matthias, Erwin Dreesen, Ruth Van Daele, Pieter Annaert, Yves Debaveye, Joost Wauters, and Isabel Spriet.
2021. "Pharmacokinetic/Pharmacodynamic Target Attainment Based on Measured versus Predicted Unbound Ceftriaxone Concentrations in Critically Ill Patients with Pneumonia: An Observational Cohort Study" Antibiotics 10, no. 5: 557.
https://doi.org/10.3390/antibiotics10050557
APA Style
Gijsen, M., Dreesen, E., Van Daele, R., Annaert, P., Debaveye, Y., Wauters, J., & Spriet, I.
(2021). Pharmacokinetic/Pharmacodynamic Target Attainment Based on Measured versus Predicted Unbound Ceftriaxone Concentrations in Critically Ill Patients with Pneumonia: An Observational Cohort Study. Antibiotics, 10(5), 557.
https://doi.org/10.3390/antibiotics10050557